FY 2018 WISEWOMAN / Wise Choices Procedure Code Reference Chart

Size: px
Start display at page:

Download "FY 2018 WISEWOMAN / Wise Choices Procedure Code Reference Chart"

Transcription

1 99203 Office or other outpatient visit for the evaluation and management of a new patient, a detailed history; a detailed examination; and medical decision making of low complexity. Usually the presenting problem(s) are of moderate. Physicians typically spend Office or other outpatient visit for the evaluation and management of a new patient, a comprehensive history; a comprehensive examination; and medical decision making of moderate complexity. Usually the presenting problem(s) are of moderate to high. Physicians typically spend Initial comprehensive preventive medicine evaluation and management of an individual /risk factor reduction interventions, and the ordering of appropriate immunizations(s), laboratory/diagnostic procedures, new patient; years Initial comprehensive preventive medicine evaluation and management of an individual /risk factor reduction interventions, and the ordering of appropriate immunizations(s), laboratory/diagnostic procedures, new patient; years Initial comprehensive preventive medicine evaluation and management of an individual /risk factor reduction interventions, and the ordering of appropriate immunizations(s), laboratory/diagnostic procedures, new patient; 65 years and over Straightforward problem of moderate Detailed history and P/E needed high glucose, or high blood pressure ( Alert or Emergency values) Complex problem of moderate to high Comprehensive history and P/E needed high glucose, and high blood pressure New patient between the ages of 18 and 39 New patient between the ages of 40 and 64 New patient age 65 and older FY18 1

2 99201 Office or other outpatient visit for the evaluation and management of a new patient, a problem focused history; a problem focused examination; and Usually, the presenting problems are self limited or minor. Physicians typically spend Office or other outpatient visit for the evaluation and management of a new patient, an expanded problem focused history; an expanded problem focused examination; and Usually, the presenting problem(s) are of low to moderate. Physicians typically spend Office or other outpatient visit for the evaluation and management of an established patient, which requires at least two of these three key components: an expanded problem focused history; an expanded problem focused examination; medical decision making of low complexity. Counseling and coordination of care with other providers or agencies are provided Usually, the presenting problem(s) are of low to moderate. Physicians typically spend Office or other outpatient visit for the evaluation and management of an established patient, which requires at least two of these three key components: Minor problem Problem focused history and P/E needed and treatment of borderline cholesterol. Straightforward problem of low/moderate Problem focused history and P/E needed high glucose, or high blood pressure (not Alert values) Straightforward problem of low/moderate Problem focused history and P/E needed high glucose, or high blood pressure Complex problem of moderate to high FY18 2

3 a detailed history; a detailed examination; medical decision making of moderate complexity. Usually the presenting problem(s) are of moderate to high. Physicians typically spend Periodic comprehensive preventive medicine reevaluation and management of an counseling/anticipatory /risk factor reduction interventions, and the ordering of appropriate immunization(s), laboratory/diagnostic procedures, established patient; years Periodic comprehensive preventive medicine reevaluation and management of an counseling/anticipatory /risk factor reduction interventions, and the ordering of appropriate immunization(s), laboratory/diagnostic procedures, established patient; years Periodic comprehensive preventive medicine reevaluation and management of an counseling/anticipatory /risk factor reduction interventions, and the ordering of appropriate immunization(s), laboratory/diagnostic procedures, established patient; 65 years and over Office or other outpatient visit for the evaluation and management of an established patient, that may not require the presence of a physician. Usually, the presenting problem(s) are minimal. Typically, 5 minutes are spent performing or supervising these services Office or other outpatient visit for the evaluation and management of an established patient, which requires at least two of these three components: a problem focused history; Comprehensive history and P/E needed high glucose, and high blood pressure Established patient between the ages of Established patient between the ages of Established patient age 65 and older and treatment of borderline cholesterol. Minor problem FY18 3

4 FY 2018 a problem focused examination; Usually, the presenting problem(s) are self limited or minor. Physicians typically spend Lipid panel. This panel must include the following: Cholesterol, serum, total Lipoprotein, direct measurement, high density cholesterol (HDL Cholesterol) Triglycerides QW Lipid panel. This panel must include the following: Cholesterol, serum, total Lipoprotein, direct measurement, high density cholesterol (HDL Cholesterol) Triglycerides (CLIA waived) high glucose, or high blood pressure (not Alert values) Lipid panel (TC, HDL, triglycerides) Lipid panel (TC, HDL, triglycerides) Test performed with Cholestech Collection of venous blood by venipuncture Venipuncture Glucose; quantitative, blood (except reagent strip) Plasma Glucose QW Glucose; quantitative, blood (except reagent strip) (CLIA waived) Plasma Glucose Test performed with Cholestech Hemoglobin; glycosylated (A1C) Hemoglobin A1C QW Hemoglobin; glycosylated (A1C) (CLIA waived) Hemoglobin A1C Performed with DCA or Cholestech GDX Unlisted preventive and medicine service Alert value case management Unlisted cardiovascular service or procedure Hypertension case management T1023 Screening to determine the appropriateness of an individual for participation in a New WISEWOMAN recruited specified program FY18 4

5 S5190 Wellness assessment, performed by a non physician Client is not ready to change: Make f/u call in 1 2 months S0315 Disease management program, initial assessment and initiation Client initiates medication adherence S0340 Lifestyle modification program for management of CVD 1st stage Client participated in 1 st health coaching session or Lifestyle Program encounter S0341 Lifestyle modification program for management of CVD 2 nd or 3 rd stage Client participates in two health coaching sessions after health coaching or LSP is complete S0342 Lifestyle modification program for management of CVD final stage Client completes health coaching or Lifestyle Program S0316 Disease management program, follow up/reassessment Outcome evaluation contact completed S T Patient education not otherwise listed non physician provider Preventive behavior change, intensive program of prevention of diabetes using a standardized diabetes prevention program curriculum, provided to individuals in a group setting, minimum 60 minutes, per day Client exhibits positive changes on outcome evaluation contact Client attends a Diabetes Prevention Program session FY18 5

Clinical Breast Examination N/A Yes Screening Mammogram $ TC $ 43.56

Clinical Breast Examination N/A Yes Screening Mammogram $ TC $ 43.56 For the Period 07/01/2015 through 06/30/2016 Revised: 10/09/2015 Breast Procedures (1) Screening Clinical Breast Examination N/A Screening Mammogram 77057 $ 78.38 77057-TC $ 43.56 77057-26 $ 34.82 Follow-Up

More information

Procedure Description Modifier 33 Required? Screening test of visual acuity, quantitative, bilateral No Z Z00.129

Procedure Description Modifier 33 Required? Screening test of visual acuity, quantitative, bilateral No Z Z00.129 Policy Name: Preventive Health Guidelines - Newborns and Children This policy applies only to non-grandfathered plans as defined in the Affordable Care Act section 1251. The following chart contains procedure,

More information

FY 2015 BCCCP Procedure Code Reference Chart

FY 2015 BCCCP Procedure Code Reference Chart Procedure Reference Chart 77057 G0202 77055 G0206 77056 G0204 Screening mammography, bilateral (two view film study of each breast) Screening mammography producing direct digital image, bilateral, all

More information

FY 2017 MCRCEDP Procedure Code Reference Chart

FY 2017 MCRCEDP Procedure Code Reference Chart 45378-53 45380 45381 45382 45384 45385 48388 45390 ; Colonoscopy, flexible, proximal to splenic flexure; diagnostic, with or without collection of specimen(s) by brushing or washing, with or without colon

More information

Metabolic Monitoring Point of Care Testing

Metabolic Monitoring Point of Care Testing Metabolic Monitoring Point of Care Testing Committee on Provider Quality 5/16/18 Revised 8/2/18 Metabolic Monitoring Goals Identify treatable pathology in a high risk population and link to medical care

More information

2017 Employee Wellness Health Assessment Report

2017 Employee Wellness Health Assessment Report Employee Wellness National Consortium for Building Healthy Academic Communities (BHAC) Healthier Tennessee Workplace 2017 Employee Wellness Health Assessment Report Blood Pressure 2017 (387 total) (National

More information

INDIANA HEALTH COVERAGE PROGRAMS

INDIANA HEALTH COVERAGE PROGRAMS INDIANA HEALTH COVERAGE PROGRAMS PROVIDER CODE TABLES Medical Review Team s Due to possible changes in Indiana Health Coverage Programs (IHCP) policy or national coding updates, inclusion of a code on

More information

Self-monitoring blood cholesterol (SMBC) testing: within-person day to day variation in a healthy volunteer

Self-monitoring blood cholesterol (SMBC) testing: within-person day to day variation in a healthy volunteer Address: Self-monitoring blood cholesterol (SMBC) testing: within-person day to day variation in a healthy volunteer Lipid Clinic, Department of Cardiology Basingstoke & North Hampshire Hospital Aldermaston

More information

Achieving Bright Futures

Achieving Bright Futures Implementation of the ACA Pediatric Preventive Services Provision To ensure that all services children need are provided, it is critical that insurers pay for each separately reported service at a level

More information

Nutrition Care Process. Catherine Villafranca & Anthony Richitt

Nutrition Care Process. Catherine Villafranca & Anthony Richitt Nutrition Care Process Catherine Villafranca & Anthony Richitt Nutrition Care Process -According to eatrightpro.org, the Nutrition Care Process is a systematic approach to providing high-quality nutrition

More information

NOTE: Please append modifier 33 when indicated. If modifier 33 is not appended, regular plan benefits will be applied.

NOTE: Please append modifier 33 when indicated. If modifier 33 is not appended, regular plan benefits will be applied. Policy name: Health Guidelines - Men This policy applies only to non-grandfathered plans as defined in the Affordable Care Act section 1251. The following chart contains procedure, diagnosis and modifier

More information

2013 Hypertension Measure Group Patient Visit Form

2013 Hypertension Measure Group Patient Visit Form Please complete the form below for 20 or more unique patients meeting patient sample criteria for the measure group for the current reporting year. A majority (11 or more) patients must be Medicare Part

More information

Customer Bulletin January 2017

Customer Bulletin January 2017 Customer Bulletin January 2017 Revised s: PTS Panels Multi-Chemistry Controls (Lot Numbers MC23, MC24, MC25, and MC26) (REF 721) Summary: New range cards has been issued for PTS Panels Multi-Chemistry

More information

8/12/2016. Outline. New CPT Code for Pre-Diabetes Education. Medicare Proposed Coverage for DPP. Medicare Proposed Coverage for DPP cont.

8/12/2016. Outline. New CPT Code for Pre-Diabetes Education. Medicare Proposed Coverage for DPP. Medicare Proposed Coverage for DPP cont. New CPT Code for Pre-Diabetes Education 0403T: Preventive behavior change, intensive program of prevention of diabetes using a standardized diabetes prevention program curriculum, provided to individuals

More information

Prevention of Fetal Alcohol Spectrum Disorder Coding Basics

Prevention of Fetal Alcohol Spectrum Disorder Coding Basics Prevention of Fetal Alcohol Spectrum Disorder Coding Basics The Centers for Disease Control and Prevention (CDC) urges pregnant women not to drink alcohol during pregnancy. Per the CDC, there is no known

More information

Clinical and Economic Summary Report. for Employers

Clinical and Economic Summary Report. for Employers Clinical and Economic Summary Report for Employers Magaly Rodriguez de Bittner, PharmD, CDE, FAPhA Director, P 3 Program Dawn Shojai, PharmD Assistant Director, P 3 Program P 3 Clinical & Economic Summary

More information

To reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees.

To reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees. E Nancy A. Haller, MPH, CHES, Manager, State Wellness Program M PLOYEES To reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees. To suspend or decrease the rising costs

More information

Table of Contents. Early Identification Chart Biometric Screening Comprehensive Cardiovascular Disease Risk Assessment...

Table of Contents. Early Identification Chart Biometric Screening Comprehensive Cardiovascular Disease Risk Assessment... Public Safety Table of Contents Early Identification Chart... 1 Biometric Screening... 2 Comprehensive Cardiovascular Disease Risk Assessment.... 2 Recommended after Comprehensive Cardiovascular Disease

More information

(a) y = 1.0x + 0.0; r = ; N = 60 (b) y = 1.0x + 0.0; r = ; N = Lot 1, Li-heparin whole blood, HbA1c (%)

(a) y = 1.0x + 0.0; r = ; N = 60 (b) y = 1.0x + 0.0; r = ; N = Lot 1, Li-heparin whole blood, HbA1c (%) cobas b system - performance evaluation Study report from a multicenter evaluation of the new cobas b system for the measurement of HbAc and lipid panel Introduction The new cobas b system provides a point-of-care

More information

Program Summary. The CT Early Detection and Prevention Program

Program Summary. The CT Early Detection and Prevention Program Program Summary The CT Early Detection and Prevention Program 1 The CT Early Detection and Prevention Program is part of the Center for Disease Control and Prevention s (CDC) National Breast and Cervical

More information

KIDNEY DISEASE is associated with a number

KIDNEY DISEASE is associated with a number PATIENT EDUCATION Column Editor: Beth McQuiston, MS, RD, LD Tips for Cholesterol Control in Patients on Hemodialysis Philippa Norton Feiertag, MEd, RD, CSR, LD Submitted by Philippa Norton Feiertag, MEd,

More information

South Bay Worksite Wellness. Health Coaching Report San Mateo County 2013 Health Coaching Program

South Bay Worksite Wellness. Health Coaching Report San Mateo County 2013 Health Coaching Program South Bay Worksite Wellness Health Coaching Report Health Coaching Program Introduction Project Details Services were delivered to employees who are Kaiser Permanente members. Telephonic outreach was completed

More information

MEDICAL POLICY MEDICAL POLICY DETAILS POLICY STATEMENT. Page: 1 of 6

MEDICAL POLICY MEDICAL POLICY DETAILS POLICY STATEMENT. Page: 1 of 6 Page: 1 of 6 MEDICAL POLICY MEDICAL POLICY DETAILS Medical Policy Title MEDICAL/ NON-SURGICAL WEIGHT MANAGEMENT PROGRAMS and SERVICES Policy Number 11.01.01 Category Contract Clarification Effective Date

More information

Session 21: Heart Health

Session 21: Heart Health Session 21: Heart Health Heart disease and stroke are the leading causes of death in the world for both men and women. People with pre-diabetes, diabetes, and/or the metabolic syndrome are at higher risk

More information

NOTE: Please append modifier 33 when indicated. If modifier 33 is not appended, regular plan benefits will be applied.

NOTE: Please append modifier 33 when indicated. If modifier 33 is not appended, regular plan benefits will be applied. Policy name: Preventive Health Guidelines - Men The following chart contains procedure and diagnosis code combinations that identify services covered under HMSA's Preventive Health s policy. * For professional

More information

Aina Blood Monitoring System

Aina Blood Monitoring System Aina Blood Monitoring System Analytical Performance Summary The Aina Blood Monitoring System is a high quality and versatile multi-parameter diagnostic platform that is CE-marked and approved for sale

More information

Normal cholesterol level for men over 50

Normal cholesterol level for men over 50 Normal cholesterol level for men over 50 Understand what your cholesterol levels mean: Total, LDL, for men and 50 mg per dl their respective numbers have to stay over or under a particular level,. 24-4-2017

More information

Cardiac rehabilitation/secondary prevention programs

Cardiac rehabilitation/secondary prevention programs AHA/AACVPR Scientific Statement Core Components of Cardiac Rehabilitation/Secondary Prevention Programs A Statement for Healthcare Professionals From the American Heart Association and the American Association

More information

Accuracy and Precision in Point-of-Care Lipid Testing: CardioChek P A Point-of-Care Test System and PTS Panels Test Strips

Accuracy and Precision in Point-of-Care Lipid Testing: CardioChek P A Point-of-Care Test System and PTS Panels Test Strips Accuracy and Precision in Point-of-Care Lipid Testing: CardioChek P A Point-of-Care Test System and PTS Panels Test Strips Sponsored by Arthur Roberts, MD of The Living Heart Foundation The Living Heart

More information

Attention STAR Providers: Physical, Occupational, and Speech Therapy Benefits for All Ages to Change for Texas Medicaid September 1, 2017

Attention STAR Providers: Physical, Occupational, and Speech Therapy Benefits for All Ages to Change for Texas Medicaid September 1, 2017 Attention STAR Providers: Physical, Occupational, and Speech Therapy Benefits for All Ages to Change for Texas Medicaid September 1, 2017 Effective for dates of service on or after September 1, 2017, physical

More information

Preventive Cardiology

Preventive Cardiology Preventive Cardiology 21 Volume The Preventive Cardiology and Rehabilitation Prevention Outpatient Visits 7,876 Program helps patients identify traditional and Phase I Rehab 9,932 emerging nontraditional

More information

Plasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension

Plasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original

More information

B. Patient has not reached the percentage reduction goal with statin therapy

B. Patient has not reached the percentage reduction goal with statin therapy Managing Cardiovascular Risk: The Importance of Lowering LDL Cholesterol and Reaching Treatment Goals for LDL Cholesterol The Role of the Pharmacist Learning Objectives 1. Review the role of lipid levels

More information

Maryland-National Capital Park Police Prince George s County Division DIVISION DIRECTIVE DISTRIBUTION

Maryland-National Capital Park Police Prince George s County Division DIVISION DIRECTIVE DISTRIBUTION Maryland-National Capital Park Police Prince George s County Division DIVISION DIRECTIVE TITLE PROCEDURE NUMBER SECTION DISTRIBUTION EFFECTIVE DATE REVIEW DATE Administrative Procedures A 12/01/04 REPLACES

More information

Advanced Topics in DBT: The Art of Moving from Conceptualization to Exposure for Emotional Avoidance

Advanced Topics in DBT: The Art of Moving from Conceptualization to Exposure for Emotional Avoidance Conceptualization to Exposure for Emotional Avoidance This 4-day course will include one day of advanced training on DBT case conceptualization and three days of training on exposure in DBT Stage 1 and

More information

Polymer Technology Systems, Inc. CardioChek PA Comparison Study

Polymer Technology Systems, Inc. CardioChek PA Comparison Study Polymer Technology Systems, Inc. CardioChek PA Comparison Study Evaluation Protocol: Accuracy Precision Clinical Correlation PTS Panels Lipid Panel Test Strips For Use in Comparisons to a Reference Laboratory

More information

Director, Employee Health & Productivity. Coordinator, Employee Health & Productivity

Director, Employee Health & Productivity. Coordinator, Employee Health & Productivity Director, Employee Health & Productivity Coordinator, Employee Health & Productivity Table 2:. ChartE: Female HDL Cholesterol Risk Levels Optimal Borderline High Risk 80% 60% 40% 20% 0% LDL Cholesterol

More information

1 PROTOCOL. Comparison Study Summary. Springs Memorial Hospital. Springs Memorial Hospital 800 W. Meeting St. Lancaster, SC (803)

1 PROTOCOL. Comparison Study Summary. Springs Memorial Hospital. Springs Memorial Hospital 800 W. Meeting St. Lancaster, SC (803) Comparison Study Summary Springs Memorial Hospital 800 W. Meeting St. Lancaster, SC 29720 (803) 286-1480 February 10, 2016 1 PROTOCOL This evaluation was conducted on February 10, 2016 at Springs Memorial

More information

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension Module 2 Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension 1 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,

More information

Heart Disease and Diabetes Teaching Module

Heart Disease and Diabetes Teaching Module Heart Disease and Diabetes eaching Module Pre-est 1 Cardiovascular complications will affect of people with diabetes. a. 75% b. 15% c. 99% 2 rue or alse? Chronic high blood sugars can cause arteries to

More information

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: 2014 PQRS MEASURES IN ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP: #204. Ischemic Vascular Disease (IVD):

More information

Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines

Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines Paul Mahoney, MD Sentara Cardiology Specialists Lipid Management in Cardiovascular Disease

More information

Lipoprotein Particle Profile

Lipoprotein Particle Profile Lipoprotein Particle Profile 50% of people at risk for HEART DISEASE are not identified by routine testing. Why is LPP Testing The Most Comprehensive Risk Assessment? u Provides much more accurate cardiovascular

More information

2/27/2017. Point of Care Testing- current and future opportunities for pharmacists in Virginia. Financial Disclosures. Pre-Assessment.

2/27/2017. Point of Care Testing- current and future opportunities for pharmacists in Virginia. Financial Disclosures. Pre-Assessment. Point of Care Testing- current and future opportunities for pharmacists in Virginia Objectives Define the Pharmacy Practice Act in Virginia M AR G AR E T L AN D I S, P H AR M. D. K R O G E R P H AR M AC

More information

Evidence-Based Medicine

Evidence-Based Medicine Assessing Risks for Cardiovascular Disease in a Pharmacy Setting Jeff Rochon, Pharm.D. Director of Pharmacy Care Services Washington State Pharmacy Association Evidence-Based Medicine Use established guidelines

More information

Diabetic Dyslipidemia

Diabetic Dyslipidemia Diabetic Dyslipidemia Dr R V S N Sarma, M.D., (Internal Medicine), M.Sc., (Canada), Consultant Physician Cardiovascular disease (CVD) is a significant cause of illness, disability, and death among individuals

More information

SCIENTIFIC STUDY REPORT

SCIENTIFIC STUDY REPORT PAGE 1 18-NOV-2016 SCIENTIFIC STUDY REPORT Study Title: Real-Life Effectiveness and Care Patterns of Diabetes Management The RECAP-DM Study 1 EXECUTIVE SUMMARY Introduction: Despite the well-established

More information

Section 02: Health Appraisal / Risk Stratification

Section 02: Health Appraisal / Risk Stratification Section 02: Health Appraisal / Risk Stratification ACSM Guidelines: Chapter 2 Pre Participation Health Screening and Risk Stratification ACSM Manual: Chapter 2 Pre Assessment Screening HPHE 4450 Dr. Cheatham

More information

Best practices for a successful wellness screening program

Best practices for a successful wellness screening program Health & Wellness Best practices for a successful wellness screening program Identify risk. Increase engagement. Incite change. Identifying health risks in your employee population People at risk for chronic

More information

Do OurHealth primary care clinics improve health & reduce healthcare costs? OurHealth Patient Engagement Analysis June 2018

Do OurHealth primary care clinics improve health & reduce healthcare costs? OurHealth Patient Engagement Analysis June 2018 Question: Do OurHealth primary care clinics improve health & reduce healthcare costs? OurHealth Patient Engagement Analysis June 2018 An examination of health improvements, utilization & cost of care for

More information

CANadian Pediatric Weight management Registry CANPWR. UPDATE ON PROGRESS CANNeCTIN Meeting 27.April.2010

CANadian Pediatric Weight management Registry CANPWR. UPDATE ON PROGRESS CANNeCTIN Meeting 27.April.2010 CANadian Pediatric Weight management Registry CANPWR UPDATE ON PROGRESS CANNeCTIN Meeting 27.April.2010 KM Morrison Hamilton (PI) Geoff Ball Edmonton, AB JP Chanoine Vancouver, BC Mark Tremblay Ottawa,

More information

Zarmine Naccashian, PhD, GNP, RN,CDE Assistant Professor, CSUN Felicitas A. dela Cruz, RN, DNSc, FAANP Professor and Director, APU Center for the

Zarmine Naccashian, PhD, GNP, RN,CDE Assistant Professor, CSUN Felicitas A. dela Cruz, RN, DNSc, FAANP Professor and Director, APU Center for the Zarmine Naccashian, PhD, GNP, RN,CDE Assistant Professor, CSUN Felicitas A. dela Cruz, RN, DNSc, FAANP Professor and Director, APU Center for the Study of Health Disparities To describe the risk factors

More information

... CME/CPE QUIZ... CME/CPE QUESTIONS

... CME/CPE QUIZ... CME/CPE QUESTIONS CME/CPE QUESTIONS Continuing Medical Education Accreditation The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 2 credit hours in category 1 credit toward

More information

4. resisted training ** OR resistance training * OR resisted exercise ** OR resistance exercise ** OR strength training ** OR strength exercise **

4. resisted training ** OR resistance training * OR resisted exercise ** OR resistance exercise ** OR strength training ** OR strength exercise ** Supplementary Table 1. Search strategy (up to January 10 th 2015). MEDLINE Result: 253 studies 1. clinical trial ** OR controlled trial ** OR randomized controlled trial * OR randomised controlled trial

More information

Evaluating the Impact of a Pharmacist-Care Program for Persons with Diabetes

Evaluating the Impact of a Pharmacist-Care Program for Persons with Diabetes Evaluating the Impact of a Pharmacist-Care Program for Persons with Diabetes Prepared for: National Community Pharmacists Association Foundation by: David Nau, R.Ph., Ph.D. Assistant Professor Josh Blevins

More information

NOTE: Please append modifier 33 when indicated. If modifier 33 is not appended, regular plan benefits will be applied.

NOTE: Please append modifier 33 when indicated. If modifier 33 is not appended, regular plan benefits will be applied. Policy name: Preventive Health Guidelines - Men The following chart contains procedure and diagnosis code combinations that identify services covered under HMSA's Preventive Health s policy. * For professional

More information

2013 UPDATE ON PREVENTION & SCREENING IN THE ELDERLY West Virginia Geriatrics Society October 3, 2013

2013 UPDATE ON PREVENTION & SCREENING IN THE ELDERLY West Virginia Geriatrics Society October 3, 2013 2013 UPDATE ON PREVENTION & SCREENING IN THE ELDERLY West Virginia Geriatrics Society October 3, 2013 Joy Pelfrey, RN, MSN, FNP, NEA-BC Director of Senior Service Line Objective Providers will understand

More information

Case Study: Chris Arden. Peripheral Arterial Disease

Case Study: Chris Arden. Peripheral Arterial Disease Case Study: Chris Arden Peripheral Arterial Disease Patient Presentation Diane is a 65-year-old retired school teacher She complains of left calf pain when walking 50 metres; the pain goes away after she

More information

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Know Your Number Aggregate Report Single Analysis Compared to National Averages Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics

More information

Evidence-Based Medicine

Evidence-Based Medicine Assessing Risks for Cardiovascular Disease in a Pharmacy Setting Jeff Rochon, Pharm.D. Director of Pharmacy Care Services Washington State Pharmacy Association Evidence-Based Medicine Use established guidelines

More information

ATP III (Adult Treatment Panel III) CLASSIFICATION C IN ADULTS

ATP III (Adult Treatment Panel III) CLASSIFICATION C IN ADULTS LABORATORY AND RISK FACTORS OF ATHEROSCLEROSIS S R. Mohammadi Biochemist (Ph.D.) Faculty member of Medical Faculty RISK FACTORS FOR CHD Clinical Risk Factors Laboratory Risk Factors MAJOR CLINICAL RISK

More information

Key Elements in Managing Diabetes

Key Elements in Managing Diabetes Key Elements in Managing Diabetes Presentor Disclosure No conflicts of interest to disclose Presented by Susan Cotey, RN, CDE Lennon Diabetes Center Stephanie Tubbs Jones Health Center Cleveland Clinic

More information

Primary Prevention Patients aged 85yrs and over

Primary Prevention Patients aged 85yrs and over Rotherham Guideline for the management of Non-Familial Hypercholesterolaemia Type 1 Diabetes Offer lifestyle advice Over 40yrs of age? Diabetic for more than 10 years? Established nephropathy? Other CVD

More information

Client Report Screening Program Results For: Missouri Western State University October 28, 2013

Client Report Screening Program Results For: Missouri Western State University October 28, 2013 Client Report For: Missouri Western State University October 28, 2013 Executive Summary PROGRAM OVERVIEW From 1/1/2013-9/30/2013, Missouri Western State University participants participated in a screening

More information

Measure Owner Designation. AMA-PCPI is the measure owner. NCQA is the measure owner. QIP/CMS is the measure owner. AMA-NCQA is the measure owner

Measure Owner Designation. AMA-PCPI is the measure owner. NCQA is the measure owner. QIP/CMS is the measure owner. AMA-NCQA is the measure owner 2011 EHR Measure Specifications The specifications listed in this document have been updated to reflect clinical practice guidelines and applicable health informatics standards that are the most current

More information

Hospital Authority Convention 2010 Presented by : Dr Cheng Ming Kin Medical Officer,Department of Medicine Tseung Kwan O Hospital

Hospital Authority Convention 2010 Presented by : Dr Cheng Ming Kin Medical Officer,Department of Medicine Tseung Kwan O Hospital Hospital Authority Convention 2010 Prevalence of Cardiovascular Risk Factors, the Metabolic Syndrome and the 10-year risk for Coronary Heart Disease in the Staff of Tseung Kwan O Hospital Presented by

More information

Daniel M. Rosney, Sr.

Daniel M. Rosney, Sr. Work Address: Department of Kinesiology P244 Pearson Hall 215.204.2974 daniel.rosney@temple.edu Revised 08/17 EDUCATION Ph.D. in Exercise and Nutrition Sciences 2017 B.S./M.S. in Exercise Science/Nutrition

More information

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein

More information

Why are NICE guidelines and standards important and relevant to us?

Why are NICE guidelines and standards important and relevant to us? Why are NICE guidelines and standards important and relevant to us? Dr Liz England GP, Laurie Pike health centre RCGP Mental Health Clinical and Commissioning Lead SWB CCG Mental Health Lead NIHR Clinical

More information

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION 2 Hyperlipidemia Andrew Cohen, MD and Neil S. Skolnik, MD CONTENTS INTRODUCTION RISK CATEGORIES AND TARGET LDL-CHOLESTEROL TREATMENT OF LDL-CHOLESTEROL SPECIAL CONSIDERATIONS OLDER AND YOUNGER ADULTS ADDITIONAL

More information

COMMUNITY EFFORTS TO PREVENT TYPE 2 DIABETES

COMMUNITY EFFORTS TO PREVENT TYPE 2 DIABETES COMMUNITY EFFORTS TO PREVENT TYPE 2 DIABETES 15 th Population Health Colloquium March 23, 2015 Marti Macchi, MEd., MPH Senior Consultant National Association of Chronic Disease Directors Today s Agenda

More information

THE EFFECT OF VITAMIN-C THERAPY ON HYPERGLYCEMIA, HYPERLIPIDEMIA AND NON HIGH DENSITY LIPOPROTEIN LEVEL IN TYPE 2 DIABETES

THE EFFECT OF VITAMIN-C THERAPY ON HYPERGLYCEMIA, HYPERLIPIDEMIA AND NON HIGH DENSITY LIPOPROTEIN LEVEL IN TYPE 2 DIABETES Int. J. LifeSc. Bt & Pharm. Res. 2013 Varikasuvu Seshadri Reddy et al., 2013 Review Article ISSN 2250-3137 www.ijlbpr.com Vol. 2, No. 1, January 2013 2013 IJLBPR. All Rights Reserved THE EFFECT OF VITAMIN-C

More information

Why do we need SD LipidoCare?

Why do we need SD LipidoCare? SD Biosensor, Inc. Innovative Global Leader of In Vitro Diagnostics Total supplier of Blood Glucose Monitoring System and Lipid Analyzer System in vitro diagnostics test kits for Point of Care Testing

More information

Keywords: Type 2 DM, lipid profile, metformin, glimepiride ABSTRACT

Keywords: Type 2 DM, lipid profile, metformin, glimepiride ABSTRACT Human Journals Research Article September 2015 Vol.:4, Issue:2 All rights are reserved by K. Saravanan et al. Effects of Monotherapy and Combination Therapy Involving Metformin and Glimepiride on HbA1c

More information

Improving Target LDL-C Levels in Diabetic Patients Using the Electronic Health Record: Primary Care Practice Improvement Project

Improving Target LDL-C Levels in Diabetic Patients Using the Electronic Health Record: Primary Care Practice Improvement Project University of Portland Pilot Scholars Nursing Graduate Publications and Presentations School of Nursing 2015 Improving Target LDL-C Levels in Diabetic Patients Using the Electronic Health Record: Primary

More information

Ohio. SAMPLE NCCI Edits*** Navigate to the Overall Coding Sheet

Ohio. SAMPLE NCCI Edits*** Navigate to the Overall Coding Sheet SAMPLE NCCI *** Encounter +90785 Use 90785 in conjunction with codes for diagnostic psychiatric evaluation [90791, 90792], psychotherapy [90832, 90834, 90837], psychotherapy when performed with an evaluation

More information

Prevention and Management Of Obesity Adolescents & Children

Prevention and Management Of Obesity Adolescents & Children Prevention and Management Of Obesity Adolescents & Children The Pediatric Obesity Prevention and Treatment Toolkit is available at: https://www.optimahealth.com/providers/clinical-reference/pediatric-obesity-prevention-andtreatment-toolkit

More information

Gender: M Chart No: Fasting: Yes. Boston Heart HDL Map TM Test 1 ApoA-I (mg/dl) levels in HDL particles. α Range > <14 mg/dl. α-2 50.

Gender: M Chart No: Fasting: Yes. Boston Heart HDL Map TM Test 1 ApoA-I (mg/dl) levels in HDL particles. α Range > <14 mg/dl. α-2 50. Pro vider: Ordering Provider 123 Main Street Anytown, ST 12345 Account No: DOB: 00/00/1950 Framingham Risk Score: Patient Info: FAMILY HIST CVD Lipid, Lipoprotein and Apolipoprotein Tests Total Cholesterol

More information

Alere Cholestech LDX Laboratory Procedure Lipid Profile GLU TC HDL GLU TC GLU Lipid Profile TC HDL TC

Alere Cholestech LDX Laboratory Procedure Lipid Profile GLU TC HDL GLU TC GLU Lipid Profile TC HDL TC Laboratory Name: Laboratory Address: Date of this packet: Insert Revision: 26196en Rev. A 2010/12 Alere Cholestech LDX Laboratory Procedure Lipid Profile GLU TC HDL GLU TC GLU Lipid Profile TC HDL TC This

More information

The National Diabetes Prevention Program in Washington State March 2012

The National Diabetes Prevention Program in Washington State March 2012 The National Diabetes Prevention Program in Washington State March 2012 Session Objectives 1. Overview of pre-diabetes. 2. Describe the Diabetes Prevention Program (DPP). 3. Eligibility for the DPP. 4.

More information

Section 1: 1: Trends. Section 2: 2: Comparisons to to Overall Portland Area Area Results for for

Section 1: 1: Trends. Section 2: 2: Comparisons to to Overall Portland Area Area Results for for Section 1: 1: Trends 1 Patients in the Diabetes Register 2 Gender of Patients with Diabetes 2 Age of Patients with Diabetes 3 Diabetes Type 3 Duration of Diabetes 4 Weight Control 5 Hemoglobin A1c 6 Blood

More information

WISEWOMAN/Wise Choices Policy Manual

WISEWOMAN/Wise Choices Policy Manual WISEWOMAN/Wise Choices Policy Manual Fiscal Year 2017/2018 October 1, 2017 to September 30, 2018 WISEWOMAN/Wise Choices Program Policies Table of Contents MDHHS Contact Information 3 WISEWOMAN Program

More information

The New Gold Standard for Lipoprotein Analysis. Advanced Testing for Cardiovascular Risk

The New Gold Standard for Lipoprotein Analysis. Advanced Testing for Cardiovascular Risk The New Gold Standard for Lipoprotein Analysis Advanced Testing for Cardiovascular Risk Evolution of Lipoprotein Testing The Lipid Panel Total Cholesterol = VLDL + LDL + HDL Evolution of Lipoprotein Testing

More information

Diabetes, Diet and SMI: How can we make a difference?

Diabetes, Diet and SMI: How can we make a difference? Diabetes, Diet and SMI: How can we make a difference? Dr. Adrian Heald Consultant in Endocrinology and Diabetes Leighton Hospital, Crewe and Macclesfield Research Fellow, Manchester University Relative

More information

Coach on Call. Please give me a call if you have more questions about this or other topics.

Coach on Call. Please give me a call if you have more questions about this or other topics. Coach on Call It was great to talk with you. Thank you for your interest in. I hope you find this tip sheet helpful. Please give me a call if you have more questions about this or other topics. As your

More information

Screening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016

Screening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016 Juniata College Screening Results Juniata College Screening Results October 11, 2016 & October 12, 2016 JUNIATA COLLEGE The J.C. Blair Hospital CARES team screened 55 Juniata College employees on October

More information

Diabetes Mellitus. Eiman Ali Basheir. Mob: /1/2019

Diabetes Mellitus. Eiman Ali Basheir. Mob: /1/2019 Diabetes Mellitus Eiman Ali Basheir Mob: 091520385 27/1/2019 Learning Outcomes Discuss the WHO criteria for Diabetes Mellitus diagnosis Describe the steps taken to confirm diagnosis Interpret GTT. Discuss

More information

CLINICAL GUIDELINE. Document No:CG38 *All Sites Management of adult patients referred to South Tees University Hospitals for hypertension.

CLINICAL GUIDELINE. Document No:CG38 *All Sites Management of adult patients referred to South Tees University Hospitals for hypertension. GUIDELINE CLINICAL GUIDELINE Document No:CG38 *All Sites Management of adult patients referred to South Tees University Hospitals for hypertension. TITLE Management of adult patients referred to South

More information

All-in-One Portable Lipid Analyzer

All-in-One Portable Lipid Analyzer All-in-One Portable Lipid Analyzer Small in Size! Big in Performance! Clinically proven accuracy & precision Evaluation study Extensive clinical studies proved the accuracy of the SD LipidoCare system

More information

Diabetes Management: Interventions Engaging Community Health Workers

Diabetes Management: Interventions Engaging Community Health Workers Diabetes Management: Interventions Engaging Community Health Workers Community Preventive Services Task Force Finding and Rationale Statement Ratified April 2017 Table of Contents Intervention Definition...

More information

15/9/2017 4:23:00PM 15/9/2017 4:26:23PM 20/9/2017 5:00:25PM A/c Status. Test Name Results Units Bio. Ref. Interval < >40.00 mg/dl <150.

15/9/2017 4:23:00PM 15/9/2017 4:26:23PM 20/9/2017 5:00:25PM A/c Status. Test Name Results Units Bio. Ref. Interval < >40.00 mg/dl <150. Lab No 135091257 Age 30 Years Gender Male 15/9/2017 42300M 15/9/2017 42623M 20/9/2017 50025M Ref By UNKNWON Final Test Results Units Bio Ref Interval SWASTH LUS DIABETES ANEL LIID ROFILE, BASIC, SERUM

More information

Mipomersen (ISIS ) Page 2 of 1979 Clinical Study Report ISIS CS3

Mipomersen (ISIS ) Page 2 of 1979 Clinical Study Report ISIS CS3 (ISIS 301012) Page 2 of 1979 2 SYNOPSIS ISIS 301012-CS3 synopsis Page 1 Title of Study: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics,

More information

Total Wellness BIOMETRIC SCREENING. What is Biometric Screening? MVNA Biometric Screening includes:

Total Wellness BIOMETRIC SCREENING. What is Biometric Screening? MVNA Biometric Screening includes: Total Wellness BIOMETRIC SCREENING What is Biometric Screening? MVNA Biometric Screening includes: BODY MASS INDEX BLOOD PRESSURE BLOOD SUGAR LIPID PROFILE 1 Why do we screen? These numbers are among the

More information

Effects of a Community Pharmacist-Based Diabetes Patient-Management Program on Intermediate Clinical Outcome Measures

Effects of a Community Pharmacist-Based Diabetes Patient-Management Program on Intermediate Clinical Outcome Measures RESEARCH Effects of a Community Pharmacist-Based Diabetes Patient-Management Program on Intermediate Clinical Outcome Measures OBJECTIVES: Evaluate a community pharmacist-based diabetes patient-management

More information

Diabetes Audit Results, Portland Area, Site-Specific Trends

Diabetes Audit Results, Portland Area, Site-Specific Trends Site-Specific Trends The following report contains information from your program's annual diabetes audit submission to the Indian Health Service over the past few years. The report was prepared for your

More information

Evidence-Based Medicine

Evidence-Based Medicine Assessing Risks for Cardiovascular Disease: Blood Pressure Measurement and Lipid Profile Screenings Jeff Rochon, Pharm.D. Director of Pharmacy Care Services Washington State Pharmacy Association Evidence-Based

More information

ORIGINAL REPORTS: CHRONIC DISEASE MANAGEMENT AND PREVENTION

ORIGINAL REPORTS: CHRONIC DISEASE MANAGEMENT AND PREVENTION ORIGINAL REPORTS: CHRONIC DISEASE MANAGEMENT AND PREVENTION QUALITY IMPROVEMENT FOR PREVENTION OF CARDIOVASCULAR DISEASE AND STROKE IN AN ACADEMIC FAMILY MEDICINE CENTER: DO RACIAL DIFFERENCES IN OUTCOME

More information

What is Diabetes Mellitus?

What is Diabetes Mellitus? Normal Glucose Metabolism What is Diabetes Mellitus? When the amount of glucose in the blood increases, After a meal, it triggers the release of the hormone insulin from the pancreas. Insulin stimulates

More information

Task Force Finding and Rationale Statement

Task Force Finding and Rationale Statement Cardiovascular Disease Prevention and Control: Reducing Out-of- Pocket Costs for Cardiovascular Disease Preventive Services for Patients with High Blood Pressure and High Cholesterol Task Force Finding

More information

Comprehensive Treatment for Dyslipidemias. Eric L. Pacini, MD Oregon Cardiology 2012 Cardiovascular Symposium

Comprehensive Treatment for Dyslipidemias. Eric L. Pacini, MD Oregon Cardiology 2012 Cardiovascular Symposium Comprehensive Treatment for Dyslipidemias Eric L. Pacini, MD Oregon Cardiology 2012 Cardiovascular Symposium Primary Prevention 41 y/o healthy male No Medications Normal BP, Glucose and BMI Social History:

More information